Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Deciding between cash back and rewards credit cards? This guide helps you compare features to find the best option for your financial goals.
26,399 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Early retirees who keep working may see Social Security checks reduced by an annual earnings limit. This article expl...
Kinross Gold posted a solid Q4 print after the bell, beating expectations with $0.67 in adjusted EPS and outlining 20...
AI-driven demand and easing supply bottlenecks push chipmakers into the spotlight. Here’s a timely look at the best s...
As Medicare costs rise with MAGI, retirees are turning to a tax-efficient move: roll assets from a traditional 401K t...
Markets are sizzling, but does that change the wisdom of simply following the S&P 500? This guide breaks down the rea...
With Johnson & Johnson stock hovering near mid-230s, investors are weighing if a $300 target is in reach this year as...
A Florida grocery worker allegedly exploited lottery access to scan scratch-offs, netting tens of thousands in winnin...
Nvidia surged into the spotlight as a long-term wealth engine for many investors. This guide asks the hard question: ...
A new JPMORGAN CHASE INSTITUTE study shows american small business bills tripled in 2025 as tariff costs surged, pres...
Three wall street giants are signaling a path for Nvidia to reach $300 by year-end 2026, anchored in accelerating ent...
A widow may see a meaningful, lifelong boost by switching from spousal survivor to survivor benefits. This article ex...